[Federal Register Volume 66, Number 103 (Tuesday, May 29, 2001)]
[Notices]
[Pages 29157-29158]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13333]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Treatment Research Subcommittee.
    Date: June 7-8, 2001.
    Time: 9 AM to 3 PM.
    Agenda: To review and evaluate grant applications.
    Place: Radisson Barcelo Hotel, 2121 P Street NW, Washington, DC 
20037.
    Contact Person: Kesinee Nimit, MD, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1432.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Health Services Research Subcommittee.
    Date: June 7-8, 2001.
    Time: 9 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: Radisson Barcelo Hotel, 2121 P Street NW, Washington, DC 
20037.
    Contact Person: Marina L. Volkov, Ph.D, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1433.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Treatment Research.
    Date: June 7, 2001.
    Time: 1 PM to 4 PM.
    Agenda: To review and evaluate grant applications.
    Place: Radisson Barcelo Hotel, 2121 P Street NW, Washington, DC 
20037.
    Contact Person: Mark R. Green, Ph.D, Chief, CEASRB, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, Suite 3158, 6001 Executive Boulevard, 
Bethesda, MD 20892-9547, (301) 435-1431.

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, International Studies on Drug Abuse and HIV/AIDS.
    Date: June 27, 2001.
    Time: 8 AM to 6 PM.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 1600 Rhode Island Ave., NW., 
Washington, DC 20037.
    Contact Person: William C. Grace, Ph.D, Deputy Director, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Center Review Committee.
    Date: July 9, 2001.
    Time: 8:30 AM to 4 PM.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Pentagon City, 1250 S. Hayes Street, 
Arlington, VA 22202.
    Contact Person: Rita Liu, Ph.D, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Medication Development Research Subcommittee.
    Date: July 9-10, 2001.
    Time: 9 AM to 6 PM.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Grand, 2350 M Street, NW, Washington, DC 
20037.
    Contact Person: Khursheed Asghar, Ph.D, Chief, Basic Sciences 
Review Branch, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, 6001 Executive Boulevard, 
Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group, Training and Career Development Subcommittee.
    Date: July 10-11, 2001.
    Time: 8 AM to 6 PM.
    Agenda: To review and evaluate grant applications.
    Place: Ritz Carlton-Pentagon City, Arlington, VA.
    Contact Person: Mark Swieter, Ph.D, Health Scientist 
Administrator, Office of Extramural Affairs, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 6001 Executive 
Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, (301) 435-
1389.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Medication Development.
    Date: July 10, 2001.
    Time: 10 AM to 3 PM.
    Agenda: To review and evaluate grant applications.
    Place: The Westin Grand Hotel, 2350 M Street, NW, Washington, DC 
20037.
    Contact Person: Rita Liu, Ph.D, Health Scientist Administrator, 
Office of Extramural Affairs, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 6001 Executive Boulevard, Room 
3158, MSC 9547, Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Responding to Club Drugs and Other Emerging and 
Current Drug Abuse Trends.
    Date: July 11-12, 2001.
    Time: 8 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: The Melrose Hotel, 2430 Pennsylvania Ave., NW., 
Washington, DC 20037.
    Contact Person: William C. Grace, Ph.D, Deputy Director, Office 
of Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, Research on GHB and its Precursors.
    Date: July 16-17, 2001.
    Time: 9 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Pentagon City, 1250 S. Hayes Street, 
Arlington, VA 22202.
    Contact Person: Rita Liu, Ph.D, Health Scientist Administrator, 
Office of Extramural

[[Page 29158]]

Affairs, National Institute on Drug Abuse, National Institutes of 
Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 9547, 
Bethesda, MD 20892-9547, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, The Next Generation of Drug Abuse Prevention 
Research.
    Date: July 17, 2001.
    Time: 9 AM to 5 PM.
    Agenda: To review and evaluate grant application.
    Place: The Hyatt Regency Hotel, 100 Bethesda Metro Center, 
Bethesda, MD 20814.
    Contact Person: Teresa Levitin, Ph.D, Director, Office of 
Extramural Affairs, National Institute on Drug Abuse, National 
Institutes of Health, DHHS, 6001 Executive Boulevard, Room 3158, MSC 
9547, Bethesda, MD 20892-9547, (301) 443-2755.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel, HIV/AIDS and Drug use Among Adolescents.
    Date: July 18, 2001.
    Time: 9 AM to 5 PM.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, 7400 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: Marina L. Volkov, Ph.D, Health Scientist 
Administrator, Office of Extramural Program Review, National 
Institute on Drug Abuse, National Institutes of Health, DHHS, 6001 
Executive Boulevard, Room 3158, MSC 9547, Bethesda, MD 20892-9547, 
(301) 435-1433.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)


    Dated: May 22, 2001.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 01-13333 Filed 5-25-01; 8:45 am]
BILLING CODE 4140-01-M